Clinical impact through AI-assisted MS care
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 13 projects and 0 programmes
Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions
Biomarkers in atopic dermatitis and psoriasis
H2O Health outcomes observatory
Health initiatives in psoriasis and psoriatic arthritis consortium European states
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients
Rheuma Tolerance for Cure
Be The Cure
Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases
Unrestricted leveraging of targets for research advancement and drug discovery